DR. DANIEL DE I. G. CUBERO

DR. DANIEL DE I. G. CUBERO

CRM: 98.992

Diretor Clínico e Oncologista

DR. DANIEL DE I. G. CUBERO

CRM: 98.992

Diretor Clínico e Oncologista

Títulos

Título de Doutorado em Ciências da Saúde
2015

Especialidade: Cancerologia Clínica
2013

Título Especialista Oncologia Clínica
2005

Título Especialista Cancerologia
2005

Diplomas e Certificados

Homenagem Harvard
2013

Harvard 4 Day Workshop
2012

Harvard PPCR
2012

Mestrado em Ciências da Saúde - Área de Concentração: Medicina
2010

Residência Médica Especialista em Oncologia - AC Camargo
2005

Fundamentos Básicos para Profissionais de Pesquisa Clínica
2005

Residência Clínica Médica
2002

Certificado Ético Profissional
2000

Diploma de Medicina
2000

Ensino e Pesquisa

Consultório

  • Un. SA: Rua Catequese, 199, Jardim
  • Un. SCS: Rua Osvaldo Cruz, 130, Santa Paula
  • Un. SBC: Rua Jose Versolato, 111 Bloco B Sala 2009 - Centro
  • Un. DIADEMA: Rua Orense, 41 sala 909 - Centro
  • Central de Atendimento: (11) 4228-1514

Trabalhos Publicados

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
2020

Evaluation of the systemic and therapeutic repercussions caused by drug interactions in oncology patients
2019

The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis
2019

The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients
2018

Epidemiological profile of Brazilian oncological patients seen by a reference oncology center of the public health system and who migrate in search of adequate health care
2018

Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors
2018

Medical Student Oncology Congress: Designed and Implemented by Brazilian Medical Students
2017

Curcuma longa (Turmeric) for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Pilot Study
2017

Purified Dry Paullinia cupana (PC-18) Extract for Chemotherapy-Induced Fatigue: Results of Two Double-Blind Randomized Clinical Trials
2017

Uncaria tomentosa (Cat’s Claw) Improves Quality of Life in Patients with Advanced Solid Tumors
2015

Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression
2015

Bournout in Medical Oncology Fellows: a Prospective Multicenter Cohort Study in Brazilian Institutions
2015

Pain and quality of life in patients undergoing radiotherapy for spinal metastatic disease treatment
2013

Tegafur-uracil (UFT) in lower doses is safe for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle
2013

Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial
2013

Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle
2012

Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients
2012

Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study
2011

Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study
2009

WhatsApp chat